Search research articles
Contact Us
Filters
Showing results (111-120 of 138) with videos related to
Page
of 14
Sort By:
Expert Opinion on Drug Safety
|
January 31, 2023
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patients
Matteo Megna, Elisa Camela, Teresa Battista, et al.
Journal of Clinical Medicine
|
March 25, 2022
Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications
Claudio Marasca, Maria Carmela Annunziata, Elisa Camela, et al.
Expert Opinion on Drug Safety
|
January 31, 2023
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients
Matteo Megna, Elisa Camela, Teresa Battista, et al.
Expert Opinion on Biological Therapy
|
July 22, 2024
The role of bDMARDs in the prevention and treatment of inflammatory-related comorbidities in Psoriatic Arthritis
Francesco Caso, Mauro Fatica, Mario Ferraioli, et al.
International Journal of Dermatology
|
July 13, 2024
Short-term efficacy of tildrakizumab on difficult-to-treat areas: a real-world experience
Sara Cacciapuoti, Luca Potestio, Lucia Gallo, et al.
Journal of Clinical Medicine
|
April 28, 2023
The Use of JAK/STAT Inhibitors in Chronic Inflammatory Disorders
Giuseppina Caiazzo, Anna Caiazzo, Maddalena Napolitano, et al.
Journal of Translational Medicine
|
April 1, 2024
Very low-calorie ketogenic diet (VLCKD): a therapeutic nutritional tool for acne?
Ludovica Verde, Evelyn Frias-Toral, Sara Cacciapuoti, et al.
The Journal of Dermatological Treatment
|
January 27, 2025
Safety of interleukin inhibitors in patients with plaque psoriasis and history of neoplasms: a multicenter retrospective study - IL PSO (Italian landscape psoriasis)
Mario Valenti, Luciano Ibba, Sara Di Giulio, et al.
Dermatology and Therapy
|
April 16, 2025
Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study
Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli, et al.
Clinical and Experimental Dermatology
|
April 16, 2025
A Long-Term Real-Life Safety Study of Guselkumab in Psoriasis Patients with Infectious Comorbidities, Malignancies or Heart Disease: The EARLY Study
Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 138) with videos related to
Sort By:
Page
of 14
Expert Opinion on Drug Safety
|
January 31, 2023
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patients
Matteo Megna, Elisa Camela, Teresa Battista, et al.
Journal of Clinical Medicine
|
March 25, 2022
Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications
Claudio Marasca, Maria Carmela Annunziata, Elisa Camela, et al.
Expert Opinion on Drug Safety
|
January 31, 2023
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients
Matteo Megna, Elisa Camela, Teresa Battista, et al.
Expert Opinion on Biological Therapy
|
July 22, 2024
The role of bDMARDs in the prevention and treatment of inflammatory-related comorbidities in Psoriatic Arthritis
Francesco Caso, Mauro Fatica, Mario Ferraioli, et al.
International Journal of Dermatology
|
July 13, 2024
Short-term efficacy of tildrakizumab on difficult-to-treat areas: a real-world experience
Sara Cacciapuoti, Luca Potestio, Lucia Gallo, et al.
Journal of Clinical Medicine
|
April 28, 2023
The Use of JAK/STAT Inhibitors in Chronic Inflammatory Disorders
Giuseppina Caiazzo, Anna Caiazzo, Maddalena Napolitano, et al.
Journal of Translational Medicine
|
April 1, 2024
Very low-calorie ketogenic diet (VLCKD): a therapeutic nutritional tool for acne?
Ludovica Verde, Evelyn Frias-Toral, Sara Cacciapuoti, et al.
The Journal of Dermatological Treatment
|
January 27, 2025
Safety of interleukin inhibitors in patients with plaque psoriasis and history of neoplasms: a multicenter retrospective study - IL PSO (Italian landscape psoriasis)
Mario Valenti, Luciano Ibba, Sara Di Giulio, et al.
Dermatology and Therapy
|
April 16, 2025
Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study
Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli, et al.
Clinical and Experimental Dermatology
|
April 16, 2025
A Long-Term Real-Life Safety Study of Guselkumab in Psoriasis Patients with Infectious Comorbidities, Malignancies or Heart Disease: The EARLY Study
Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli, et al.
Page
of 14